- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
Finder makes money from featured partners, but editorial opinions are our own.
Advertiser disclosure
Takeda Pharmaceutical Co Ltd ADR is a drug manufacturers - specialty & generic business based in the US. Takeda Pharmaceutical Co Ltd ADR shares (TAK) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $13.57 – a decrease of 4.1% over the previous week. Takeda Pharmaceutical Co Ltd ADR employs 49,281 staff and has a trailing 12-month revenue of around $4.4 trillion.
What's in this guide?
- TAK shares summary
- Compare share dealing platforms
- Is TAK stock a buy or sell?
- Stock performance over time
- Can I short TAK shares?
- Are TAK shares over-valued?
- Takeda Pharmaceutical Co Ltd ADR's financials
- How volatile are TAK shares?
- Does Takeda Pharmaceutical Co Ltd ADR pay a dividend?
- Other common questions
Our top picks for where to buy Takeda Pharmaceutical Co Ltd ADR stock
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Takeda Pharmaceutical Co Ltd ADR stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – TAK. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Takeda Pharmaceutical Co Ltd ADR stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.1 - 4 of 4
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Takeda Pharmaceutical Co Ltd ADR stock price (NYSE: TAK)
Use our graph to track the performance of TAK stocks over time.Takeda Pharmaceutical Co Ltd ADR shares at a glance
Information last updated 2024-10-25.
| Latest market close | $13.57 |
|---|---|
| 52-week range | $12.29 - $14.73 |
| 50-day moving average | $14.59 |
| 200-day moving average | $13.99 |
| Wall St. target price | $16.01 |
| PE ratio | 44.5161 |
| Dividend yield | $188 (4.22%) |
| Earnings per share (TTM) | $0.31 |
Is it a good time to buy Takeda Pharmaceutical Co Ltd ADR stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Takeda Pharmaceutical Co Ltd ADR price performance over time
Historical closes compared with the close of $13.57 from 2024-10-25
| 1 week (2024-10-21) | -4.10% |
|---|---|
| 1 month (2024-09-27) | -6.67% |
| 3 months (2024-07-26) | -1.45% |
| 6 months (2024-04-26) | 4.14% |
| 1 year (2023-10-27) | 0.74% |
|---|---|
| 2 years (2022-10-28) | 2.80% |
| 3 years (2021-10-28) | 14.11 |
| 5 years (2019-10-28) | 17.6 |
Is Takeda Pharmaceutical Co Ltd ADR stock undervalued or overvalued?
Valuing Takeda Pharmaceutical Co Ltd ADR stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Takeda Pharmaceutical Co Ltd ADR's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Takeda Pharmaceutical Co Ltd ADR's P/E ratio
Takeda Pharmaceutical Co Ltd ADR's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 45x. In other words, Takeda Pharmaceutical Co Ltd ADR shares trade at around 45x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Takeda Pharmaceutical Co Ltd ADR's PEG ratio
Takeda Pharmaceutical Co Ltd ADR's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 0.6911. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Takeda Pharmaceutical Co Ltd ADR's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Takeda Pharmaceutical Co Ltd ADR's EBITDA
Takeda Pharmaceutical Co Ltd ADR's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1,174.3 billion.
The EBITDA is a measure of a Takeda Pharmaceutical Co Ltd ADR's overall financial performance and is widely used to measure a its profitability.
Takeda Pharmaceutical Co Ltd ADR financials
| Revenue TTM | $4,413.1 billion |
|---|---|
| Operating margin TTM | 15.92% |
| Gross profit TTM | $2,441.7 billion |
| Return on assets TTM | 2.05% |
| Return on equity TTM | 2.04% |
| Profit margin | 3.4% |
| Book value | $4,970.05 |
| Market Capitalization | $44.3 billion |
TTM: trailing 12 months
Takeda Pharmaceutical Co Ltd ADR share dividends
Dividend payout ratio: 3.38% of net profits
Recently Takeda Pharmaceutical Co Ltd ADR has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Takeda Pharmaceutical Co Ltd ADR shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Takeda Pharmaceutical Co Ltd ADR's case, that would currently equate to about $188 per share.
While Takeda Pharmaceutical Co Ltd ADR's payout ratio might seem low, this can signify that Takeda Pharmaceutical Co Ltd ADR is investing more in its future growth.
Takeda Pharmaceutical Co Ltd ADR's most recent dividend payout was on 7 July 2024. The latest dividend was paid out to all shareholders who bought their shares by 26 March 2024 (the "ex-dividend date").
Takeda Pharmaceutical Co Ltd ADR share price volatility
Over the last 12 months, Takeda Pharmaceutical Co Ltd ADR's shares have ranged in value from as little as $12.287 up to $14.7347. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Takeda Pharmaceutical Co Ltd ADR's is 0.498. This would suggest that Takeda Pharmaceutical Co Ltd ADR's shares are less volatile than average (for this exchange).
Takeda Pharmaceutical Co Ltd ADR overview
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, immunology, oncology, and neuroscience. The company provides its products under the Entyvio, Gattex/Revestive, Takecab/Vocinti, EOHILIA, Alofisel, Dexilant, Pantoloc/Controloc, Adynovate/Adynovi, Feiba, Recombinate, Hemofil/Immunate/Immunine, Takhzyro, Livtencity, ADZYNMA, Elaprase, Replagal, Advate, Flexbumin, Vpriv, Gammagard Liquid/Kiovig, Hyqvia, Cuvitru, Exkivity, FRUZAQLA, Ninlaro, Velcade, Azilva-F, Lotriga, Iclusig, Leuplin/Enantone, Adcetris, vyvanse/elvanse, Trintellix, QDENGA, and Alunbrig brands. It has in-license agreement with BioMarin, Luxna Biotech, GlaxoSmithKline, Halozyme, and Kamada; collaboration with Neurocrine Biosciences, Inc. , Seagen Inc. , Anima Biotech, Denali Therapeutics, KSQ Therapeutics, Noile-Immune Biotech, Center for iPS Cell Research Application, Kyoto University (CiRA), and Charles River Laboratories; licensing agreement with Mirum Pharmaceuticals and Twist Bioscience, UCSD/Fortis Advisors, PeptiDream, MD Anderson Cancer Center, Teva Pharmaceutical Industries, and Xenetic Biosciences; collaboration and licensing agreement with Arrowhead Pharmaceuticals Inc. , Engitix, Genevant Sciences Corporation, Sosei Heptares, Zedira/Dr.
Frequently asked questions
What percentage of Takeda Pharmaceutical Co Ltd ADR is owned by insiders or institutions?Currently 0.009% of Takeda Pharmaceutical Co Ltd ADR shares are held by insiders and 2.312% by institutions. How many people work for Takeda Pharmaceutical Co Ltd ADR?
Latest data suggests 49,281 work at Takeda Pharmaceutical Co Ltd ADR. When does the fiscal year end for Takeda Pharmaceutical Co Ltd ADR?
Takeda Pharmaceutical Co Ltd ADR's fiscal year ends in March. Where is Takeda Pharmaceutical Co Ltd ADR based?
Takeda Pharmaceutical Co Ltd ADR's address is: 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 What is Takeda Pharmaceutical Co Ltd ADR's ISIN number?
Takeda Pharmaceutical Co Ltd ADR's international securities identification number is: US8740602052 What is Takeda Pharmaceutical Co Ltd ADR's CUSIP number?
Takeda Pharmaceutical Co Ltd ADR's Committee on Uniform Securities Identification Procedures number is: 874060106
More resources on Finder
More guides on Finder
-
How to buy Zentek stock (ZTEK)
Steps to owning and managing ZTEK, with 24-hour and historical pricing before you buy.
-
How to buy ATAI Life Sciences stock (Atai Life Sciences)
Steps to owning and managing ATAI, with 24-hour and historical pricing before you buy.
-
How to buy Seelos Therapeutics stock (SEEL)
Steps to owning and managing SEEL, with 24-hour and historical pricing before you buy.
-
How to buy Eli Lilly and Company stock (LLY)
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
-
How to buy Humana stock (HUM)
Steps to owning and managing HUM, with 24-hour and historical pricing before you buy.
-
How to buy Illumina stock (ILMN)
Steps to owning and managing ILMN, with 24-hour and historical pricing before you buy.
-
How to buy UnitedHealth Group Incorporated stock (UNH)
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
-
How to buy Pfizer stock (PFE)
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
-
How to buy Moderna stock (MRNA)
Steps to owning and managing MRNA, with 24-hour and historical pricing before you buy.
-
How to buy Johnson & Johnson stock (JNJ)
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.
Ask a question